CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 55 enrolled
Drug / intervention
Subcutaneous tissue release with the Cabochon Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01671839
NCT01671839N/ACompleted

Pivotal Study of the Cabochon System for Improvement in the Appearance of Cellulite

Merz North America, Inc.·interventional·Posted Aug 24, 2012·Updated Dec 10, 2019

In Brief

A clinical study evaluating Subcutaneous tissue release with the Cabochon System for Gynoid Lipodystrophy. Completed, enrolled 55 participants across 3 sites.

Detailed Summary

The purpose of this study is to evaluate the safety and effectiveness of the Cabochon System for the improvement in the appearance of cellulite.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
CollaboratorsUlthera, Inc

Timeline

N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedAug 24, 2012
Enrollment StartAug 1, 2012
Primary CompletionSep 1, 2013
Study CompletionDec 1, 2015
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 13.9 years ago

Interventions

Subcutaneous tissue release with the Cabochon Systemdevice

Device: Subcutaneous tissue release